FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016568689> ?p ?o ?g. }

• W2016568689 endingPage "F47" @default.
• W2016568689 startingPage "F41" @default.
• W2016568689 abstract "The routine use of phenotypic drug resistance testing in patient management has revealed that many HIV-1 strains possess significantly increased drug sensitivity, or 'hypersusceptibility' compared with wild-type viruses. This study describes hypersusceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTI) and was designed to determine the prevalence of and viral characteristics associated with NNRTI hypersusceptibility in patient-derived viruses.Retrospective analyses were performed on a large clinical laboratory dataset containing phenotypic drug susceptibility and genotypic sequence results from HIV-1 patient isolates. Genetically engineered viruses were used to confirm the role of certain nucleoside reverse transcriptase inhibitor (NRTI)-resistance mutations in NNRTI hypersusceptibility.Hypersusceptibility to delavirdine, efavirenz and nevirapine was detected in 10.7, 10.8 and 8.0% of more than 17,000 consecutive plasma samples submitted for phenotypic susceptibility testing. In analyses limited to a subset of viruses derived from patients with known treatment histories, NNRTI hypersusceptibility was observed significantly more frequently among viruses from NRTI experienced/NNRTI-naive patients compared with viruses from NRTI/NNRTI-naive patients. Significant inverse correlations between NRTI and NNRTI susceptibility exist among the viruses from NRTI-experienced patients. Analyses of viruses classified according to their NNRTI susceptibility identified 18 positions in reverse transcriptase where substitutions were significantly associated with NNRTI hypersusceptibility.NNRTI hypersusceptibility is common among patient HIV-1 isolates, especially in NRTI-resistant viruses. Genotypic correlates of hypersusceptibility are complex and not easily defined by a simple analysis of NRTI-associated resistance mutations. NNRTI hypersusceptibility may provide an explanation for the superior virologic response to NNRTI-containing salvage regimens observed in NRTI-experienced patients in several clinical trials." @default.
• W2016568689 created "2016-06-24" @default.
• W2016568689 creator A5001024279 @default.
• W2016568689 creator A5032190280 @default.
• W2016568689 creator A5034553895 @default.
• W2016568689 creator A5036101551 @default.
• W2016568689 creator A5042931433 @default.
• W2016568689 creator A5044401686 @default.
• W2016568689 creator A5044865465 @default.
• W2016568689 creator A5049124473 @default.
• W2016568689 creator A5063704053 @default.
• W2016568689 creator A5086021121 @default.
• W2016568689 date "2002-10-01" @default.
• W2016568689 modified "2023-10-10" @default.
• W2016568689 title "Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1" @default.
• W2016568689 cites W1744409238 @default.
• W2016568689 cites W1970307257 @default.
• W2016568689 cites W1989692384 @default.
• W2016568689 cites W2008954911 @default.
• W2016568689 cites W2026323517 @default.
• W2016568689 cites W2058530732 @default.
• W2016568689 cites W2084702672 @default.
• W2016568689 cites W2168910994 @default.
• W2016568689 doi "https://doi.org/10.1097/00002030-200210180-00002" @default.
• W2016568689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12370521" @default.
• W2016568689 hasPublicationYear "2002" @default.
• W2016568689 type Work @default.
• W2016568689 sameAs 2016568689 @default.
• W2016568689 citedByCount "91" @default.
• W2016568689 countsByYear W20165686892012 @default.
• W2016568689 countsByYear W20165686892013 @default.
• W2016568689 countsByYear W20165686892014 @default.
• W2016568689 countsByYear W20165686892015 @default.
• W2016568689 countsByYear W20165686892016 @default.
• W2016568689 countsByYear W20165686892017 @default.
• W2016568689 countsByYear W20165686892023 @default.
• W2016568689 crossrefType "journal-article" @default.
• W2016568689 hasAuthorship W2016568689A5001024279 @default.
• W2016568689 hasAuthorship W2016568689A5032190280 @default.
• W2016568689 hasAuthorship W2016568689A5034553895 @default.
• W2016568689 hasAuthorship W2016568689A5036101551 @default.
• W2016568689 hasAuthorship W2016568689A5042931433 @default.
• W2016568689 hasAuthorship W2016568689A5044401686 @default.
• W2016568689 hasAuthorship W2016568689A5044865465 @default.
• W2016568689 hasAuthorship W2016568689A5049124473 @default.
• W2016568689 hasAuthorship W2016568689A5063704053 @default.
• W2016568689 hasAuthorship W2016568689A5086021121 @default.
• W2016568689 hasConcept C104317684 @default.
• W2016568689 hasConcept C114851261 @default.
• W2016568689 hasConcept C135763542 @default.
• W2016568689 hasConcept C142462285 @default.
• W2016568689 hasConcept C156719811 @default.
• W2016568689 hasConcept C159047783 @default.
• W2016568689 hasConcept C2522874641 @default.
• W2016568689 hasConcept C2776452011 @default.
• W2016568689 hasConcept C2777351918 @default.
• W2016568689 hasConcept C2779130552 @default.
• W2016568689 hasConcept C2779690655 @default.
• W2016568689 hasConcept C2780727368 @default.
• W2016568689 hasConcept C2781432083 @default.
• W2016568689 hasConcept C2909970146 @default.
• W2016568689 hasConcept C2993143319 @default.
• W2016568689 hasConcept C49105822 @default.
• W2016568689 hasConcept C54355233 @default.
• W2016568689 hasConcept C86803240 @default.
• W2016568689 hasConceptScore W2016568689C104317684 @default.
• W2016568689 hasConceptScore W2016568689C114851261 @default.
• W2016568689 hasConceptScore W2016568689C135763542 @default.
• W2016568689 hasConceptScore W2016568689C142462285 @default.
• W2016568689 hasConceptScore W2016568689C156719811 @default.
• W2016568689 hasConceptScore W2016568689C159047783 @default.
• W2016568689 hasConceptScore W2016568689C2522874641 @default.
• W2016568689 hasConceptScore W2016568689C2776452011 @default.
• W2016568689 hasConceptScore W2016568689C2777351918 @default.
• W2016568689 hasConceptScore W2016568689C2779130552 @default.
• W2016568689 hasConceptScore W2016568689C2779690655 @default.
• W2016568689 hasConceptScore W2016568689C2780727368 @default.
• W2016568689 hasConceptScore W2016568689C2781432083 @default.
• W2016568689 hasConceptScore W2016568689C2909970146 @default.
• W2016568689 hasConceptScore W2016568689C2993143319 @default.
• W2016568689 hasConceptScore W2016568689C49105822 @default.
• W2016568689 hasConceptScore W2016568689C54355233 @default.
• W2016568689 hasConceptScore W2016568689C86803240 @default.
• W2016568689 hasIssue "15" @default.
• W2016568689 hasLocation W20165686891 @default.
• W2016568689 hasLocation W20165686892 @default.
• W2016568689 hasOpenAccess W2016568689 @default.
• W2016568689 hasPrimaryLocation W20165686891 @default.
• W2016568689 hasRelatedWork W1785188379 @default.
• W2016568689 hasRelatedWork W178626500 @default.
• W2016568689 hasRelatedWork W2014257673 @default.
• W2016568689 hasRelatedWork W2043953605 @default.
• W2016568689 hasRelatedWork W2078842080 @default.
• W2016568689 hasRelatedWork W2108373753 @default.
• W2016568689 hasRelatedWork W2140384375 @default.
• W2016568689 hasRelatedWork W2166878266 @default.
• W2016568689 hasRelatedWork W2562860486 @default.
• W2016568689 hasRelatedWork W3155579397 @default.

• next